Protocol 10553, "A Phase 2 Study of Darolutamide in Combination with Leuprolide Acetate in Hormone-Therapy Naive Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer,"

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

University of Colorado Hospital

Principal Investigator
Photograph of Daniel Bowles

Daniel Bowles

Study ID

Protocol Number: 23-0845

More information available at ClinicalTrials.gov: NCT05669664

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers